Outlook Therapeutics (OTLK) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

OTLK is expected to report earnings to rise 22.92% to -98 cents per share on May 15

Outlook Therapeutics OTLK Stock Earnings Reports

Q1'24

Est.

$-0.98

Q4'23

Beat

by $0.19

Q3'23

Missed

by $0.94

Q2'23

Missed

by $1.55

Q1'23

Missed

by $0.54

The last earnings report on February 14 showed earnings per share of -80 cents, beating the estimate of -99 cents. With 150.97K shares outstanding, the current market capitalization sits at 184.92M.

View a ticker or compare two or three

Compare

OTLK

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For OTLK
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for OTLK (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

485 Route 1 South Building F

Phone

+1 609 619-3990

Employees

Web

https://www.outlooktherapeutics.com